198 related articles for article (PubMed ID: 7848347)
1. Pharmacology of the new selective A2a adenosine receptor agonist 2-hexynyl-5'-N-ethylcarboxamidoadenosine.
Monopoli A; Conti A; Zocchi C; Casati C; Volpini R; Cristalli G; Ongini E
Arzneimittelforschung; 1994 Dec; 44(12):1296-304. PubMed ID: 7848347
[TBL] [Abstract][Full Text] [Related]
2. Telemetry monitoring of hemodynamic effects induced over time by adenosine agonists in spontaneously hypertensive rats.
Casati C; Monopoli A; Forlani A; Bonizzoni E; Ongini E
J Pharmacol Exp Ther; 1995 Nov; 275(2):914-9. PubMed ID: 7473182
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of the highly selective A1 adenosine receptor agonist 2-chloro-N6-cyclopentyladenosine.
Monopoli A; Conti A; Dionisotti S; Casati C; Camaioni E; Cristalli G; Ongini E
Arzneimittelforschung; 1994 Dec; 44(12):1305-12. PubMed ID: 7848348
[TBL] [Abstract][Full Text] [Related]
4. Prolonged exposure to 5'-N-ethylcarboxamidoadenosine (NECA) does not affect the adenosine A2A-mediated vasodilation in porcine coronary arteries.
Conti A; Lozza G; Monopoli A
Pharmacol Res; 1997 Feb; 35(2):123-8. PubMed ID: 9175581
[TBL] [Abstract][Full Text] [Related]
5. Humoral effects of selective adenosine agonists in spontaneously hypertensive rats.
Sala C; Monopoli A; Alberti C; Casati C; Ongini E; Zanchetti A; Morganti A
J Hypertens; 1996 Jan; 14(1):75-9. PubMed ID: 12013498
[TBL] [Abstract][Full Text] [Related]
6. Repeated administration of selective adenosine A1 and A2 receptor agonists in the spontaneously hypertensive rat: tolerance develops to A1-mediated hemodynamic effects.
Casati C; Monopoli A; Dionisotti S; Zocchi C; Bonizzoni E; Ongini E
J Pharmacol Exp Ther; 1994 Mar; 268(3):1506-11. PubMed ID: 8138961
[TBL] [Abstract][Full Text] [Related]
7. The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.
Zocchi C; Ongini E; Conti A; Monopoli A; Negretti A; Baraldi PG; Dionisotti S
J Pharmacol Exp Ther; 1996 Feb; 276(2):398-404. PubMed ID: 8632302
[TBL] [Abstract][Full Text] [Related]
8. Effects of repeated administration of selective adenosine A1 and A2A receptor agonists on pentylenetetrazole-induced convulsions in the rat.
Adami M; Bertorelli R; Ferri N; Foddi MC; Ongini E
Eur J Pharmacol; 1995 Dec; 294(2-3):383-9. PubMed ID: 8750698
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective effects of adenosine A1 and A2A receptor agonists in the isolated rat heart.
Lozza G; Conti A; Ongini E; Monopoli A
Pharmacol Res; 1997 Jan; 35(1):57-64. PubMed ID: 9149317
[TBL] [Abstract][Full Text] [Related]
10. 2-alkenyl and 2-alkyl derivatives of adenosine and adenosine-5'-N-ethyluronamide: different affinity and selectivity of E- and Z-diastereomers at A2A adenosine receptors.
Vittori S; Camaioni E; Di Francesco E; Volpini R; Monopoli A; Dionisotti S; Ongini E; Cristalli G
J Med Chem; 1996 Oct; 39(21):4211-7. PubMed ID: 8863798
[TBL] [Abstract][Full Text] [Related]
11. Characterization of 8-(N-methylisopropyl)amino-N6-(5'-endohydroxy- endonorbornyl)-9-methyladenine (WRC-0571), a highly potent and selective, non-xanthine antagonist of A1 adenosine receptors.
Martin PL; Wysocki RJ; Barrett RJ; May JM; Linden J
J Pharmacol Exp Ther; 1996 Feb; 276(2):490-9. PubMed ID: 8632314
[TBL] [Abstract][Full Text] [Related]
12. A1 and A2 adenosine receptor modulation of contractility in the cauda epididymis of the guinea-pig.
Haynes JM; Alexander SP; Hill SJ
Br J Pharmacol; 1998 Oct; 125(3):570-6. PubMed ID: 9806342
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of adenosine A2 agonists in the conscious spontaneously hypertensive rat: a comparative study of three structurally distinct ligands.
Webb RL; Barclay BW; Graybill SC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1203-12. PubMed ID: 1684818
[TBL] [Abstract][Full Text] [Related]
14. 2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies.
Franchetti P; Cappellacci L; Marchetti S; Trincavelli L; Martini C; Mazzoni MR; Lucacchini A; Grifantini M
J Med Chem; 1998 May; 41(10):1708-15. PubMed ID: 9572897
[TBL] [Abstract][Full Text] [Related]
15. Negative chronotropic response to adenosine receptor stimulation in rat right atria after run training.
Priviero F; De Nucci G; Antunes E; Zanesco A
Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):741-3. PubMed ID: 15554918
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic changes do not mediate the cardioprotection induced by the A1, adenosine receptor agonist CCPA in the rabbit.
Casati C; Forlani A; Lozza G; Monopoli A
Pharmacol Res; 1997 Jan; 35(1):51-5. PubMed ID: 9149316
[TBL] [Abstract][Full Text] [Related]
17. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB
Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
[TBL] [Abstract][Full Text] [Related]
18. Study of the novel non-xanthine heterocyclic compound GU285 as a potent non-selective adenosine receptor antagonist in the rat.
Harden FA; Brown L; Quinn RJ; Harrison GJ; Headrick JP; Rose'Meyer RB; Willis RJ
Arzneimittelforschung; 2002; 52(3):175-81. PubMed ID: 11963644
[TBL] [Abstract][Full Text] [Related]
19. 2-Phenylethoxy-9-methyladenine: an adenosine receptor antagonist that discriminates between A2 adenosine receptors in the aorta and the coronary vessels from the guinea pig.
Martin PL; Ueeda M; Olsson RA
J Pharmacol Exp Ther; 1993 Apr; 265(1):248-53. PubMed ID: 8474010
[TBL] [Abstract][Full Text] [Related]
20. Mechanism and pressor relevance of the short-term cardiovascular and renin excitatory actions of the selective A2A-adenosine receptor agonists.
Alberti C; Monopoli A; Casati C; Forlani A; Sala C; Nador B; Ongini E; Morganti A
J Cardiovasc Pharmacol; 1997 Sep; 30(3):320-4. PubMed ID: 9300315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
